COO Lisa Foo sold 10,000 shares at $258.03 for $2.6M — her largest recorded sale, cutting directly held shares by 23.8% — with the stock sitting just 1.8% below its 90-day high of $262.68 and 63.7% above the 90-day low. The $2.6M size nearly doubles her prior largest sale of $1.4M in August 2025, and the near-peak timing suggests deliberate monetization rather than routine diversification, though the absence of any co-selling cluster and a 22-of-27 analyst Strong Buy consensus temper the bearish signal. Bull case: stock holds above $258 and 27-analyst consensus drives continuation toward $270+; bear case: breaks $240 support, where prior director sales in May 2026 preceded a +9% move that may have exhausted near-term upside.

Where it could go — Our conviction 5-6 officer sell signals: 51% beat SPY at 30d (avg +2.9% vs SPY, n=1574); bull holds $258, bear breaks $240.

Director James Bierman sold $1.2M worth of THC shares at $244.96, reducing his direct holdings by 13.7% while the stock traded just 2.2% below its 90-day high. This appears to be routine profit-taking after significant price appreciation rather than a concerning signal, especially with no other insider buyers in the cluster.

Where it could go — Our 1-4 conviction sells: 55% beat SPY at 30d; watch $248.82 as resistance, $179.91 as support.

CIO Paola Arbour sold 10,878 shares at $243.90 for $2.7M, reducing her directly held shares by 37.1% from 29,291 to 18,413 — with the transaction price sitting just 2.2% below the 90-day high of $248.82. This is her seventh sell and she has never bought THC in over seven years on record, a consistent pattern of one-directional liquidation that, at near-peak prices, carries more weight than routine diversification; no other officers bought in the last 60 days to offset the signal. Bull case: Strong Buy consensus from 22 of 27 analysts holds and THC sustains above $230 → prior 30d post-sell outcomes show stock can still grind higher; Bear case: breaks $220 support and the semi-annual sell cadence accelerates into a broader distribution.

Where it could go — Our conviction 5-6 officer sell signals: 51% beat SPY at 30d (n=1545, avg +3.1% vs SPY); bull holds $230, bear breaks $220.

Director Christopher Lynch sold $934K worth of THC shares at $243.44, reducing his direct holdings by 28.6% while the stock traded just 2.2% below its 90-day high. This appears to be routine profit-taking rather than a concerning signal, as Lynch has a history of selling without any buying activity and the trade lacks cluster support despite strong analyst sentiment.

Where it could go — Our 1-4 conviction sells: 55% beat SPY at 30d; watch $248.82 as resistance, $179.91 as support.

Director Kerrey sold $341K worth of THC shares at $173.12, reducing his stake by 8.8% while the stock traded just 3% above its 90-day low. This isolated sale near the bottom of the trading range contradicts the Strong Buy analyst consensus but lacks supporting cluster activity or historical pattern context.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $168 support level given unusual low-price selling behavior.

Director Kerrey sold $341K worth of THC shares at $173.12, reducing his stake by 8.8% while the stock traded just 3% above its 90-day low. This isolated sale near the bottom of the trading range contradicts the Strong Buy analyst consensus but lacks supporting cluster activity or historical pattern context.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $168 support level given unusual low-price selling behavior.

Director Kerrey sold $341K worth of THC shares at $173.12, reducing his stake by 8.8% while the stock traded just 3% above its 90-day low. This isolated sale near the bottom of the trading range contradicts the Strong Buy analyst consensus but lacks supporting cluster activity or historical pattern context.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $168 support level given unusual low-price selling behavior.

Director Kerrey sold $341K worth of THC shares at $173.12, reducing his stake by 8.8% while the stock traded just 3% above its 90-day low. This isolated sale near the bottom of the trading range contradicts the Strong Buy analyst consensus but lacks supporting cluster activity or historical pattern context.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $168 support level given unusual low-price selling behavior.

Director West Nadja sold $532K worth of THC shares, reducing her stake by 10.8% at a price just 5.5% above the 90-day low. This first-time sale by a director near a low is a notable divergence from the analyst consensus but lacks the confirming cluster of other insider sales that would make it a stronger warning.

Where it could go — Analyst mean target not provided; bear case if stock breaks the recent low of $168.11.